Skip to main content

Landenberger Foundation Gives Scripps Florida $150K for Oncogene Studies

NEW YORK (GenomeWeb News) – The Margaret Q. Landenberger Research Foundation has given a researcher at Scripps Research Institute in Florida $150,000 to fund studies of the molecular and genetic networks that can lead to cancer, Scripps said today.
 
The foundation has granted the money to Michael Conkright, assistant professor in the Department of Cancer Biology at Scripps, to fund research into oncogenes that are caused by chromosome translocation.
 
"We've discovered an entirely new complement of transcription factors that interacts with one of these oncogenes that is not present prior to the chromosomal translocation," Conkright said in a statement. “By studying the complement of gene regulators together with data on protein expression, we may be able to finally understand mechanistically how oncogenes aberrantly activate genes.”

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.